Cheaper option available for insulin

Henrietta Brewer
March 7, 2019

The new drug, called Insulin Lispro, will have a list price 50 percent lower than Humalog's current list price of about $275 per vial.

Eli Lilly has announced they will introduce a lower-priced generic version of its insulin injection Humalog in a bid to offer people with diabetes in the U.S. a cheaper treatment option.

As per trusted sources, the move comes at the wake of growing concerns pertaining to the rising drug prices, especially insulin, which has pushed several diabetes patients to cut their doses to save costs, with some cases resulting in harmful and deadly complications.

The Wall Street Journal Editor-in-Chief Matt Murray and FBN's Cheryl Casone and Lauren Simonetti on pharmaceutical companies' reportedly planning to raise drug prices in 2019. "Solutions that lower the cost of insulin at the pharmacy have been introduced in recent months, but more people need help". "We hope our announcement is a catalyst for positive change across the U.S. health-care system".

Lilly's rebranded product will be called Insulin Lispro, while Humalog, which makes $3 billion in annual sales, will remain available for those wishing to access it through existing insurance plans.

The cost of insulin for treating type 1 diabetes in the United States has almost doubled over a five-year period, leading some patients to put their own health at risk by rationing the medication. "Millions of Americans with Medicare or employer coverage will continue to face Eli Lilly's exorbitant list price".

The new insulin is a generic version of Lilly's popular Humalog.

Laura Marston vividly remembers what it's like to pay $140 for a vial of insulin. And it's a recognition that plenty of patients feeling the squeeze of these high list prices are starting to come onto Big Pharma's radar.

In December 2016, Lilly introduced the first follow-on biologic basal insulin in the US, at a reduced price compared to branded competition.

"Clearly, the insulin cartel is feeling pressure after years of price gouging a lifesaving drug", he wrote.

The goal of the authorized generic is to offer those patients, as well as those who are uninsured, a lower list price at the pharmacy counter.

The logo of Lilly is seen on a wall of the Lilly France company unit, part of the Eli Lilly and Co drugmaker group, in Fegersheim near Strasbourg, France, February 1, 2018. "Until then, it's just more hot air in D.C".

Other reports by iNewsToday